Ebos GroupASX:EBO +0.30%77 Interest Coverage is 4.09 as of Dec. 2025, which is 56% below its 10-year median of 9.38. GuruFocus rates ASX:EBO with a GF Score™ of 77/100 and a GF Value™ of A$31.49 (Significantly Undervalued). The stock has 4 warning signs investors should review. Among 91 Medical Distribution companies, Ebos Group ranks worse than 60.44% on this metric.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's
Operating Income
by its Interest Expense. Ebos Group's
Operating Income
for the
six
months ended in Dec. 2025 was A$193 Mil. Ebos Group's Interest Expense for the
six
months ended in Dec. 2025 was A$-47 Mil.
Ebos Group's interest coverage for the quarter that ended in Dec. 2025 was 4.09.
The higher the ratio, the stronger the company's financial strength is.
The historical rank and industry rank for Ebos Group's Interest Coverage or its related term are showing as below:
ASX:EBO'
s Interest Coverage Range Over the Past 10 Years
Min: 4.31 Med: 9.38 Max: 15.55
Current: 4.31
ASX:EBO's Interest Coverage is ranked worse than 60.44% of 91
companies
in the Medical Distribution industry
Industry Median: 6.92
vs ASX:EBO: 4.31
Ebos Group (ASX:EBO) Interest Coverage Explanation
Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.
Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .
Ebos Group Interest Coverage Related Terms
Ebos Group Interest Coverage Historical Data
* Premium members only.
The historical data trend for Ebos Group's Interest Coverage can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
ASX:EBO vs MCK, COR, CAH: Interest Coverage Comparison
For the Medical Distribution subindustry, Ebos Group's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ebos Group Interest Coverage vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Ebos Group's Interest Coverage distribution charts can be found below:
* The bar in red indicates where Ebos Group's Interest Coverage falls into.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ebos Group (ASX:EBO) has a Interest Coverage of 4.09 as of Dec. 2025. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Ebos Group and its competitors. This is 56% below median its historical median of 9.38. Over the past decade, Ebos Group's Interest Coverage has ranged from 4.31 to 15.55. According to the industry distribution chart, Ebos Group ranks #55 out of 91 companies in the Medical Distribution industry, placing it in the top 60.4%.
Is Ebos Group's Interest Coverage too high?
Ebos Group's current Interest Coverage of 4.09 is 56% below median its 10-year median of 9.38. Over the past 10 years, this metric has ranged from a low of 4.31 to a high of 15.55. The Medical Distribution industry median Interest Coverage is 6.92. Ebos Group's value of 4.09 is 40.9% below this industry median. Based on the distribution chart, Ebos Group ranks #55 out of 91 companies in the Medical Distribution industry, which is below the industry midpoint. Overall, Ebos Group has a GF Score™ of 77/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Ebos Group's Interest Coverage compare to MCK and COR?
According to the Medical Distribution industry distribution chart, Ebos Group ranks #55 out of 91 companies for Interest Coverage. This places Ebos Group in the lower half of its industry. The industry median Interest Coverage is 6.92. Ebos Group's value of 4.09 is 40.9% below this benchmark. Historically, Ebos Group's own Interest Coverage has ranged from 4.31 to 15.55 over the past decade. While the company's 10-year median is 9.38 vs. the industry median of 6.92, Ebos Group has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Coverage for a Medical Distribution company?
The median Interest Coverage among Medical Distribution companies is 6.92, based on 91 companies in the industry. Companies in the top quartile (top 25%) have a Interest Coverage significantly above this median, while those in the bottom quartile fall well below. However, Interest Coverage should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Ebos Group's current Interest Coverage of 4.09 is 40.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Coverage mean?
A high Interest Coverage can signal that a stock is expensive relative to its fundamentals. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Ebos Group and its competitors. For the Medical Distribution industry, the median Interest Coverage is 6.92 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ebos Group's current Interest Coverage is 4.09, which is 56% below median its own 10-year median of 9.38. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ebos Group stock overvalued right now?
Based on GuruFocus' analysis, Ebos Group (ASX:EBO) is currently considered Significantly Undervalued. The stock's GF Value™ is A$31.49, compared to a current price of A$16.76 — trading 46.8% below its estimated fair value. The current Interest Coverage is 4.09, which is 56% below median its 10-year median of 9.38 and 40.9% below the Medical Distribution industry median of 6.92. Ebos Group's overall GF Score™ is 77/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Coverage calculated?
Interest Coverage is calculated from a company's financial statements. For Ebos Group (ASX:EBO), the current Interest Coverage is 4.09 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Ebos Group (ASX:EBO) Overvalued in 2026?
Based on GuruFocus' analysis, Ebos Group stock appears to be undervalued.
The current stock price of A$16.76 is trading 46.8% below its estimated GF Value™ of A$31.49.
GuruFocus considers Ebos Group to be Significantly Undervalued.
Key valuation signals for ASX:EBO:
Interest Coverage: 4.09 (56% below median its 10-year median of 9.38)
GF Value™: A$31.49 vs. price of A$16.76 (46.8% below fair value)
Industry Position: 40.9% below the Medical Distribution median (#55 of 91)
No single metric tells the full story. See the ASX:EBO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Ebos is the largest pharmaceutical wholesaler across Australia and New Zealand. It services community pharmacies and hospitals, which contribute around 50% and 30% of revenue, respectively. Drug pricing and wholesale margins for PBS medicine are governed by the Australian government's Pharmaceutical Benefits Scheme, or PBS. Wholesale gross margins are capped at 7% for community pharmacy and 10% for hospitals, and ongoing price reform typically results in low-single-digit revenue growth. Aside from pharma distribution, Ebos operates an animal health product wholesale, manufacturing and retail business, as well as undertaking third party logistics services. These segments are smaller contributors to group revenue but due to the unregulated nature are higher-margin operations.
77GF Score
Get the complete analysis for ASX:EBO
Interest Coverage is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:EBO has been successfully added to your 
